FindTrial
Sign In

This study looks at comparison between placebo and intravenous dexmedetomidine helps reduction in pain after surgery in patients having below mid arm operations where only the desired upper limb is numb.

A Placebo controlled study to compare the effects of intra-venous dexmedetomidine on prolongation of analgesia in supraclavicular brachial plexus block for below mid arm surgeries. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/06/112848
Enrollment
62
Registered
2026-06-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Intravenous dexmedetomidine: Loading dose: 1 g/kg over 10 min started immediately after SC-BP Block Maintenance: 0.4 g/kg/hr till end of surgery Intervention2: Intravenous dexmedeto

Sponsors

PGIMS ROHTAK Pt. BD sharma University of health sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of either gender, aged between 18-65years belonging to ASA (American society of anaesthesiologist) status I-III, undergoing elective below mid-arm surgery under supraclavicular brachial plexus block and duration of surgery less than 3 hours

Exclusion criteria

Exclusion criteria: 1. Local infection at injection site or sepsis 2. Allergy to any local anaesthetic 3.Patient with known coagulopathy or an anticoagulant therapy. 4.Patient with nerve entrapment or neuropathy after trauma or diabetic neuropathy, uncontrolled diabetes. 5. Patient who refuse to give consent. 6. Pregnancy 7. Non-union fracture

Design outcomes

Primary

MeasureTime frame
To Assess the effect of intra-venous dexmedetomidine for prolongation of analgesia in supra-clavicular brachial plexus block for below mid arm surgeries.Timepoint: 30minutes , 1 hour , 6 hour ,24 hour—

Secondary

MeasureTime frame
1)Block characteristics (onset and duration ) 2)no.of attempt taken for block 3)duration of sensory block 4)duration of motor block 5)VAS 6)Any complicationsTimepoint: 1)sensory block duration is time in minutes from end of local anaesthesia injection till return of hand and finger sensation (ts) 2)motor block duration is time in minutes from end of local anaesthesia injection till return of hand and finger movement(TM) 3)VAs ( 0-100) acess at before block ,30min after block ,every 1hourly till 4 hour ,then every 30 min interval till next 2 hour—

Countries

India

Contacts

Public ContactDr Mangal Singh Ahlawat

Pt.B.D Sharma University of health sciences

Drmangalahlawat@gmail.com7015852122

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026